Skip NavigationSkip to Content

Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia

  1. Author:
    Maria, Andrea G
    Suzuki, Mari
    Berthon, Annabel
    Kamilaris, Crystal
    Demidowich, Andrew
    Lack,Justin
    Zilbermint, Mihail
    Hannah-Shmouni, Fady
    Faucz, Fabio R
    Stratakis, Constantine A
  2. Author Address

    Section on Genetics & Endocrinology, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Dr, Bethesda, MD., National Institute of Diabetes and Digestive and Kidney Disorders, Bethesda, MD., NIAID Collaborative Bioinformatics Resource (NCBR), National Institute of Allergy and Infectious Disease, Frederick, MD., Advanced Biomedical Computational Science, 160;Frederick National Laboratory for Cancer Research, Frederick, MD., Johns Hopkins University School of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baltimore, MD USA., Johns Hopkins Community Physicians at Suburban Hospital, Bethesda, MD USA.,
    1. Year: 2020
    2. Date: Feb 22
    3. Epub Date: 2019 10 22
  1. Journal: American journal of hypertension
    1. 33
    2. 2
    3. Pages: 124-130
  2. Type of Article: Article
  3. ISSN: 0895-7061
  1. Abstract:

    BACKGROUND: Somatic variants in KCNJ5 are the most common cause of primary aldosteronism (PA). There are few patients with PA in whom the disease is caused by germline variants in the KCNJ5 pottasium channel gene (familial hyperaldosteronism type III - FH-III). METHODS: A 5 year-old patient who developed hypertension due to bilateral adrenocortical hyperplasia (BAH) causing PA had negative peripheral DNA testing for any known genetic causes of PA. He was treated medically with adequate control of his PA but by the third decade of his life, due to worsening renal function, he underwent bilateral adrenalectomy. RESULTS: Focused exome sequencing in multiple nodules of his BAH uncovered a "hot-spot" pathogenic KCNJ5 variant, while repeated Sanger sequencing showed no detectable DNA defects in peripheral blood and other tissues. However, whole exome, "deep" sequencing revealed that 0.23% of copies of germline DNA did in fact carry the same KCNJ5 variant that was present in the adrenocortical nodules, suggesting low level germline mosaicism for this PA-causing KCNJ5 defect. CONCLUSIONS: Thus, this patient represents the first to our knowledge case of BAH due to a mosaic KCNJ5 defect. Undoubtedly, his milder PA compared to other known cases of FH-III, was due to his mosaicism. This case has a number of implications for the prognosis, treatment and counseling of the many patients with PA due to BAH that are seen in hypertension clinics. © American Journal of Hypertension, Ltd 2019. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

    See More

External Sources

  1. DOI: 10.1093/ajh/hpz172
  2. PMID: 31637427
  3. WOS: 000518548300006
  4. PII : 5601961

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel